After a bidding war erupted between Pfizer and Novo Nordisk over the fledgling obesity drugmaker, Metsera sided with its original suitor in a final agreement announced late Friday evening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback